Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MOH | MOLINA HEALTHCARE, INC. | 2026-04-02 18:55:44 | 137.04 | -2.34 | -1.68 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOH | 0001179929 | MOLINA HEALTHCARE, INC. | US60855R1005 | 549300NQQCEQ46YHZ591 | 134204626 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 200 OCEANGATE, SUITE 100 | LONG BEACH | CA | 90802 | UNITED STATES | US | 5624353666 | 200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802 | 200 OCEANGATE, SUITE 100, LONG BEACH, CA, 90802 | MOLINA HEALTHCARE INC | Healthcare | 1980 | Joseph Zubretsky | 19,000 | http://molinahealthcare.com | 16,000,000,000 | — | 51,500,000 | Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare. | 2026-04-02 16:12:25 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 16,000,000,000 | -1,200,000,000 | -6.9767 | 51,500,000 | -4,000,000 | -7.2072 |
| 2024 | 17,200,000,000 | -200,000,000 | -1.1494 | 55,500,000 | -2,900,000 | -4.9658 |
| 2023 | 17,400,000,000 | 1,300,000,000 | 8.0745 | 58,400,000 | 500,000 | 0.8636 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James E. Woys | Chief Operating Officer | 2025 | 800,000 | — | 4,500,109 | 0 | 56,409 | 5,356,518 |
| Jeff D. Barlow | Secretary, Chief Legal Officer | 2025 | 685,000 | — | 3,500,053 | 0 | 51,037 | 4,395,324 |
| Joseph M. Zubretsky | President, Chief Executive Officer | 2025 | 1,600,000 | — | 16,199,988 | 0 | 540,795 | 18,340,783 |
| Mark L. Keim | Chief Financial Officer | 2025 | 1,000,000 | — | 6,250,135 | 0 | 312,049 | 7,562,184 |
| Debra J. Bacon | Executive Vice President | 2025 | 675,000 | — | 2,200,066 | 0 | 48,031 | 2,931,727 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 19,000 |
| 2022 | 15,000 |
| 2021 | 14,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 45,426,000,000 | 40,650,000,000 | 34,072,000,000 |
| Cost Of Revenue | 39,488,000,000 | 34,428,000,000 | 28,669,000,000 |
| Gross Profit | 2,652,000,000 | 2,979,000,000 | 2,973,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 3,009,000,000 | 2,743,000,000 | 2,462,000,000 |
| Operating Expenses | 44,645,000,000 | 38,943,000,000 | 32,499,000,000 |
| Operating Income | 781,000,000 | 1,707,000,000 | 1,573,000,000 |
| Net Income | 472,000,000 | 1,179,000,000 | 1,091,000,000 |
| Earnings Per Share Basic | 8.93 | 20.52 | 18.91 |
| Earnings Per Share Diluted | 8.92 | 20.42 | 18.77 |
| Weighted Average Shares Outstanding Basic | 52,800,000 | 57,400,000 | 57,700,000 |
| Weighted Average Shares Outstanding Diluted | 52,900,000 | 57,700,000 | 58,100,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 4,248,000,000 | 4,662,000,000 | 4,848,000,000 |
| Marketable Securities Current | 4,008,000,000 | 4,325,000,000 | 4,259,000,000 |
| Accounts Receivable | 3,533,000,000 | 3,299,000,000 | 3,104,000,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 12,444,000,000 | 12,773,000,000 | 12,542,000,000 |
| Marketable Securities Non Current | 34,000,000 | 142,000,000 | 65,000,000 |
| Property Plant And Equipment | — | — | — |
| Other Assets Non Current | 147,000,000 | 138,000,000 | 143,000,000 |
| Total Assets Non Current | 3,120,000,000 | 2,857,000,000 | 2,350,000,000 |
| Total Assets | 15,564,000,000 | 15,630,000,000 | 14,892,000,000 |
| Accounts Payable | 1,093,000,000 | 1,331,000,000 | 1,252,000,000 |
| Deferred Revenue | 66,000,000 | 51,000,000 | 418,000,000 |
| Short Term Debt | 0 | 0 | 0 |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 7,372,000,000 | 7,896,000,000 | 8,168,000,000 |
| Long Term Debt | 3,766,000,000 | 2,923,000,000 | 2,180,000,000 |
| Other Liabilities Non Current | 173,000,000 | 120,000,000 | 124,000,000 |
| Total Liabilities Non Current | 4,123,000,000 | 3,238,000,000 | 2,509,000,000 |
| Total Liabilities | 11,495,000,000 | 11,134,000,000 | 10,677,000,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | 3,602,000,000 | 4,091,000,000 | 3,887,000,000 |
| Accumulated Other Comprehensive Income | 15,000,000 | -57,000,000 | -82,000,000 |
| Total Shareholders Equity | 4,069,000,000 | 4,496,000,000 | 4,215,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 195,000,000 | 186,000,000 | 171,000,000 |
| Share Based Compensation Expense | 47,000,000 | 116,000,000 | 115,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 145,000,000 | 78,000,000 | 778,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -221,000,000 | 115,000,000 | 328,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | -535,000,000 | 644,000,000 | 1,662,000,000 |
| Purchases Of Marketable Securities | 751,000,000 | 1,132,000,000 | 1,433,000,000 |
| Sales Of Marketable Securities | 227,000,000 | 99,000,000 | 259,000,000 |
| Acquisition Of Property Plant And Equipment | 101,000,000 | 100,000,000 | 84,000,000 |
| Acquisition Of Business | 245,000,000 | 344,000,000 | 3,000,000 |
| Other Investing Activities | -1,000,000 | -1,000,000 | -4,000,000 |
| Cash From Investing Activities | 312,000,000 | -464,000,000 | -744,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 1,000,000,000 | 1,000,000,000 | 0 |
| Issuance Of Long Term Debt | 1,100,000,000 | 740,000,000 | 0 |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 29,000,000 | -30,000,000 | 2,000,000 |
| Cash From Financing Activities | -170,000,000 | -347,000,000 | -58,000,000 |
| Change In Cash | -393,000,000 | -167,000,000 | 860,000,000 |
| Cash At End Of Period | 4,248,000,000 | 4,662,000,000 | 4,848,000,000 |
| Income Taxes Paid | 275,000,000 | 379,000,000 | 405,000,000 |
| Interest Paid | 181,000,000 | 121,000,000 | 108,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 8.93 | 20.52 | 18.91 |
| Price To Earnings Ratio | 19.4334 | 14.1837 | 19.1068 |
| Earnings Growth Rate | -56.4815 | 8.514 | 37.828 |
| Price Earnings To Growth Ratio | -0.3441 | 1.6659 | 0.5051 |
| Book Value Per Share | 77.0644 | 78.3275 | 73.0503 |
| Price To Book Ratio | 2.2519 | 3.7158 | 4.946 |
| Ebitda | 1,134,000,000 | 1,862,000,000 | 1,776,000,000 |
| Enterprise Value | 8,680,912,000 | 14,967,270,000 | 18,179,587,000 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.9255 | 0.6501 | 0.5172 |
| Capital Expenditures | — | — | — |
| Free Cash Flow | — | — | — |
| Return On Equity | 0.116 | 0.2622 | 0.2588 |
| One Year Beta | 0.1547 | 0.212 | 0.6289 |
| Three Year Beta | 0.2809 | 0.4881 | 0.6215 |
| Five Year Beta | 0.4547 | 0.787 | 0.8534 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| ZORETIC RICHARD C | Director | 2026-04-01 | 405 | A | 9,152 |
| WOLF DALE B | Director | 2026-04-01 | 405 | A | 15,396 |
| ORLANDO STEVEN J | Director | 2026-04-01 | 405 | A | 17,730 |
| Lockhart Stephen H | Director | 2026-04-01 | 405 | A | 4,147 |
| GROHOWSKI LEO P | Director | 2026-04-01 | 405 | A | 1,305 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | 2025-12-15 | CA31 | Sale (Partial) | 2025-11-12 | — | $1,001 - $15,000 |
| Byron Donalds | 2025-10-07 | FL19 | Sale | 2025-09-04 | — | $1,001 - $15,000 |
| Byron Donalds | 2025-10-07 | FL19 | Sale | 2025-09-04 | Spouse | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-09-12 | CA31 | Purchase | 2025-08-05 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-06-09 | PA08 | Purchase | 2025-05-15 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Ares Financial Consulting, LLC | 2026-03-31 | 3,260 | 24 | 135.8333 |
| GOLDMAN SACHS GROUP INC | 2025-12-31 | 68,645,887 | 395,562 | 173.5401 |
| HSBC HOLDINGS PLC | 2025-12-31 | 33,687,142 | 193,104 | 174.4508 |
| Empowered Funds, LLC | 2025-12-31 | 3,864,389 | 22,268 | 173.54 |
| Greenland Capital Management LP | 2025-12-31 | 260,310 | 1,500 | 173.54 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily S&P 500(R) Bull 2X ETF | SPUU | 190 | 34,122.1 | 0.0147 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily S&P 500(R) Bull 3X ETF | SPXL | 3,576 | 642,213.84 | 0.0113 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion Daily Healthcare Bull 3X ETF | CURE | 1,177 | 211,377.43 | 0.1282 |
| Direxion Shares ETF Trust | 2026-01-31 | Direxion HCM Tactical Enhanced US ETF | HCMT | 410 | 73,631.9 | 0.0126 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-01-31 | Invesco S&P 500 Equal Weight ETF | RSP | 993,243 | 178,376,510.37 | 0.2182 |